Press

CEO Of Mobile Anti-Counterfeiting Technology Company Outlines Three-Point Plan To U.S. Congressional Committee For Making Intellectual Property Rights More Effective.

 

Washington, DC (25 April 2017) – Dr. Ashifi Gogo, CEO of Sproxil®, a global leader in mobile-based brand protection and consumer engagement technology,  testified at a hearing held by the United States Senate Committee on the Judiciary. Titled ‘Intellectual Property – Driver of Innovation: Making Our Lives Healthier, Safer, and more Productive,’ the hearing was presided over by Senator Chuck Grassley who is chairman of the committee on the judiciary as well as co-chair of the relaunched Congressional Trademark Caucus.

The senator expressed his pleasure at the fact that companies like Sproxil who had been recipients of the Patents for Humanity award from the United States Patent and Trademark Office were testifying at the hearing about how their award winning inventions had helped communities in need across the globe. Senator Grassley noted that innovation not only directly benefits society through the creative output of innovators but through the enormous economic impact it has on the American economy. He concluded by revealing that the Patents for Humanity Program Improvement Act had been reintroduced to encourage and reward companies that innovate and use patented technology to address humanitarian needs.

In his statement on what could be done to make defending intellectual property rights more effective, Dr. Ashifi Gogo gave three courses of action which are:

• Secure supply chains and educate consumers to drive purchase decisions which make copyright theft unprofitable.
• To encourage partnerships between global e-commerce websites, content distribution platforms, and law enforcement.
• Increase inter-agency and private sector collaboration using technology platforms to share intelligence securely.

Dr. Gogo concluded with this quote: ‘Our society needs greater awareness and broad agreement to align our collective actions to reject support for intellectual property violators. We need to promote the discovery of new knowledge and innovations by individuals, corporations, research entities, and various other legitimate organizations, both large and small. I continue to believe that technology can play a key role as we work together to achieve that goal.’

Other witnesses at the hearing were: the acting assistant director of the Intellectual Property Rights Center in Washington, the General Manager Health & Life Science for Intel Corporation Ms. Kay Eron,  Dr. Conor F. Madigan, Co-Founder & COO of Kateeva, and Dr. Neal Gutterson, VP of Research & Development at DuPont Pioneer.

###

About Sproxil

Sproxil® uses mobile technology and a proprietary fraud detection platform to launch secure, data-driven consumer engagement programs globally. Sproxil’s solutions are deployed by multinational manufacturers and brands across multiple industries to prevent supply chain fraud, amplify brand awareness, and optimize marketing spend. With teams of experts in Africa, Asia and America, Sproxil has executed projects across five continents and can offer services in over 100 countries worldwide.

They have earned numerous awards and honors, including the 2009 Clinton Global Initiative Outstanding Commitment Award, the 2013 White House Champions of change award, and the 2014 Schwab Foundation for Social Entrepreneurship award for Social Entrepreneur of the year. They were also named the most innovative healthcare company in the world by Fast Company Magazine, ranking #7 overall.  In 2015, Sproxil hit the 55 million verifications mark; the highest number of fielded verifications recorded. Most recently, they were nominated for the Unilever Global Development Award category of Business in The Community’s Responsible Business Awards.

Sproxil is the only consumer loyalty and brand protection expert with both ISO 9001 and ISO 27001 certification. For more information and a full list of Sproxil’s product suite, please visit www.sproxil.com

###

Contact

Sproxil

Ireti Oluwagbemi

ireti.oluwagbemi@sproxil.com

+234 816370 2561